Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Selgas

Showing results (71-80 of 182) with videos related to

Pageof 19
Sort By:
American Journal of Nephrology|January 1, 1986
Idiopathic IgA nephropathy presenting as malignant hypertensionM Perez-Fontan, J L Miguel, M L Picazo, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Growth hormone responses to pituitary and hypothalamic stimuli in CAPD patients treated with recombinant human erythropoietinJ J Díez, J Sastre, P Iglesias, et al.
International Urology and Nephrology|July 3, 2002
Comparisons of hemodialysis and CAPD in patients over 65 years of age: a meta-analysisR Selgas, A Cirugeda, A Fernandez-Perpén, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 2000
Short-term recombinant human growth hormone therapy does not modify growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone in adult dialysis patientsP Iglesias, R Selgas, J Méndez, et al.
Nephron|January 1, 1986
Compensation by solar irradiation of depletion of 25(OH)D in CAPD patientsM E Martinez, J L Miguel, R Selgas, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 1, 1995
Transformed mesothelial cells in patients on CAPD for medium- to long-term periodsR Selgas, M Fernandez de Castro, J M Viguer, et al.
Medicina Clinica|March 5, 1983
[Left ventricular function in uremic patients on hemodialysis: echocardiographic study]P Gómez Fernández, O Ferrufino, J Oliver, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|October 1, 2011
Peritoneal dialysis is the best cost-effective alternative for maintaining dialysis treatmentJ Arrieta, A Rodríguez-Carmona, C Remón, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1996
Serum insulin and insulin-like growth factor binding protein-1 levels in adult patients undergoing peritoneal dialysisP Iglesias, C Grande, J Méndez, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|October 25, 2000
Serum level of vascular endothelial growth factor is influenced by erythropoietin treatment in peritoneal dialysis patients. (Grupo de Estudios Peritoneales de Madrid)G del Peso, R Selgas, M A Bajo, et al.
Pageof 19

Showing results (71-80 of 182) with videos related to

Sort By:
Pageof 19
American Journal of Nephrology|January 1, 1986
Idiopathic IgA nephropathy presenting as malignant hypertensionM Perez-Fontan, J L Miguel, M L Picazo, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Growth hormone responses to pituitary and hypothalamic stimuli in CAPD patients treated with recombinant human erythropoietinJ J Díez, J Sastre, P Iglesias, et al.
International Urology and Nephrology|July 3, 2002
Comparisons of hemodialysis and CAPD in patients over 65 years of age: a meta-analysisR Selgas, A Cirugeda, A Fernandez-Perpén, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 2000
Short-term recombinant human growth hormone therapy does not modify growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone in adult dialysis patientsP Iglesias, R Selgas, J Méndez, et al.
Nephron|January 1, 1986
Compensation by solar irradiation of depletion of 25(OH)D in CAPD patientsM E Martinez, J L Miguel, R Selgas, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 1, 1995
Transformed mesothelial cells in patients on CAPD for medium- to long-term periodsR Selgas, M Fernandez de Castro, J M Viguer, et al.
Medicina Clinica|March 5, 1983
[Left ventricular function in uremic patients on hemodialysis: echocardiographic study]P Gómez Fernández, O Ferrufino, J Oliver, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|October 1, 2011
Peritoneal dialysis is the best cost-effective alternative for maintaining dialysis treatmentJ Arrieta, A Rodríguez-Carmona, C Remón, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1996
Serum insulin and insulin-like growth factor binding protein-1 levels in adult patients undergoing peritoneal dialysisP Iglesias, C Grande, J Méndez, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|October 25, 2000
Serum level of vascular endothelial growth factor is influenced by erythropoietin treatment in peritoneal dialysis patients. (Grupo de Estudios Peritoneales de Madrid)G del Peso, R Selgas, M A Bajo, et al.
Pageof 19